About Johnson & Johnson
Johnson & Johnson is a global healthcare leader focused on Innovative Medicine and MedTech. The company addresses critical medical needs across oncology, immunology, neuroscience, cardiopulmonary care, cardiovascular treatment, orthopaedics, surgery, and vision.
Key Business Units & Portfolio Focus
| Segment | Strategic Focus Areas & Core Products |
|---|---|
| Innovative Medicine | Targeted therapies and pharmaceuticals across Oncology, Immunology, and Neuroscience to treat complex and life-threatening conditions. |
| Cardiovascular & MedTech | VARIPULSE pulsed-field ablation platform, CARTO cardiac mapping systems, and advanced neurovascular devices for electrophysiology and stroke care. |
| Orthopaedics & Surgery | VELYS Robotic-Assisted Solution, surgical instruments, orthopaedic implants, and tools supporting minimally invasive procedures. |
| Vision Care | ACUVUE contact lenses, TECNIS intraocular lenses, and advanced surgical platforms for cataract and refractive eye care. |
Advanced Surgical Robotics & Key Technologies
- OTTAVA Robotic Surgical System: World’s first table-integrated soft-tissue robotic surgical platform designed to reduce floor footprint and optimize operating room workflows.
- VELYS Robotic-Assisted Solution: Digital precision and procedural guidance for orthopaedic joint replacement and reconstruction surgeries.
- VARIPULSE Platform: Pulsed-field ablation (PFA) technology integrated with CARTO 3D mapping for precise treatment of cardiac arrhythmias.
- Polyphonic Digital Ecosystem: Connected digital surgery suite delivering data-driven insights and workflow optimization across operating rooms.
Strategic Milestones & Market Expansion
- July 2026 FDA Market Authorization: Granted FDA De Novo clearance in the U.S. for the OTTAVA Robotic Surgical System for general upper abdominal surgeries, significantly expanding J&J’s advanced soft-tissue surgical robotics footprint.
- Footprint Optimization: OTTAVA’s unique architecture integrates arms into the operating table, reducing physical OR footprint by 30% to 50% compared to traditional cart-mounted systems.
- Capital Allocation: J&J continues to direct capital toward high-growth, high-margin opportunities across digital surgery, structural heart solutions, and targeted biologics.
Core Clinical Applications
- Minimally Invasive & General Surgery: Robotic-assisted interventions for upper abdominal, bariatric, and hernia procedures.
- Electrophysiology & Interventional Cardiology: Cardiac mapping and pulsed-field ablation to restore normal heart rhythms.
- Joint Reconstruction & Orthopaedics: Robot-assisted total knee and hip arthroplasty to improve alignment and patient outcomes.
- Ophthalmology & Vision Health: Premium intraocular lenses for cataract treatment and daily wear contact lens innovations.